RxDoctor Payments Data

Larry Crisco, MD

Interventional Cardiology · Jacksonville, FLNPI 1952395782

Payments from drug & device makers

$71,540in general payments, 2019–2025

Across 669 payments — averaging $106.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • CSL Behring$20K
  • Medtronic$13K
  • E.r. Squibb & Sons, L.L.C.$10K
  • Avinger Inc.$9K
  • Boston Scientific$5K
  • Abiomed$2K
  • plus $12K from 54 others

What the payments were for

  • Consulting fees$3,0007%
  • Speaking & faculty fees$3,3008%
  • Travel & lodging$10,64426%
  • Food & beverage$24,28359%
  • Education$2010%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
CSL Behring8$20,150
Medtronic(2 entities)145$13,106
E.r. Squibb & Sons, L.L.C.13$9,796
Avinger Inc.54$9,351
Boston Scientific57$5,150
Abiomed18$1,848
Shockwave Medical, Inc35$1,627
Abbott47$1,579
Endologix LLC8$805
Philips North America LLC7$564
Bard Peripheral Vascular, Inc.4$521
Novartis28$469
CMS Imaging, Inc.1$456
Merck21$378
Sanofi-aventis U.S. LLC13$375
Edwards Lifesciences4$365
Biotronik Inc.16$363
Amgen15$362
Pfizer18$309
Canon Medical Systems USA, Inc.2$273
Johnson & Johnson15$265
Angiodynamics, Inc.9$238
Boehringer Ingelheim11$235
Cardiva Medical, Inc.12$213
AstraZeneca13$189
Change Healthcare Technologies, LLC2$188
Catheter Precision, Inc. FKA Ra Medical Systems, Inc.3$181
Opsens Inc.3$175
Teleflex LLC2$149
Esperion Therapeutics, Inc.7$143
Amarin Pharma, Inc.4$103
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)8$100
Acist Medical Systems, Inc.5$93
Novo Nordisk4$83
Alnylam Pharmaceuticals Inc.4$82
Stryker2$76
Kestra Medical Technology Services, Inc.3$75
Silk Road Medical, Inc.1$70
Celonova Biosciences, Inc.1$69
Regeneron Healthcare Solutions, Inc.3$65
Cardinal Health 200 LLC4$65
Chiesi USA, Inc.4$62
Kiniksa Pharmaceuticals, Ltd.3$61
Cardiovascular Systems Inc.4$56
Heartflow, Inc.1$49
Vital Connect, Inc1$42
Biosense Webster, Inc.2$37
Neuros Medical, Inc.1$37
Reflow Medical Inc2$36
Bayer2$33
Corindus Inc.1$33
Actelion Pharmaceuticals US, Inc.1$33
Venclose Inc.1$32
Kiniksa Pharmaceuticals International, PLC1$28
Impulse Dynamics (USA) Inc.1$27
Scpharmaceuticals Inc.1$27
Cordis US CORP.1$27
Sanofi1$25
United Therapeutics Corporation1$24
Lexicon Pharmaceuticals, Inc.1$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$71,540 in reported general payments places this provider in the 80th percentile of 623 interventional cardiology providers in Florida.

See all interventional cardiology providers in Florida

Medicare billing

Part B allowed, 2024
$472,746
Medicare patients
665
Services billed
2,200

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban215$205,680
EntrestoSacubitril/Valsartan151$160,292
XareltoRivaroxaban135$148,596
FarxigaDapagliflozin Propanediol101$96,780
JardianceEmpagliflozin53$55,121
Repatha SureclickEvolocumab41$34,230
BrilintaTicagrelor20$12,489
Candesartan Cilexetil116$6,408
ClopidogrelClopidogrel Bisulfate510$5,949
Ranolazine ErRanolazine58$4,556
LivaloPitavastatin Calcium12$3,865
Metoprolol Succinate249$3,419
Atorvastatin Calcium301$3,153
Rosuvastatin Calcium258$3,056
Cilostazol142$3,042

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$309$205,680215 claims
NovartisEntresto$469$160,292151 claims
Johnson & JohnsonXarelto$265$148,596135 claims
AstraZenecaFarxiga, Brilinta$189$109,269121 claims
Boehringer IngelheimJardiance$235$55,12153 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 623 interventional cardiology providers in Florida.

Other interventional cardiology in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →